Kelsey A Hand, PA
Physician Assistant · Monona
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
- Since medical school
- 16 years
- Yale University School of Medicine, 2010
Offices
3 locations · University of Wisconsin Medical Foundation Inc · 2,537 clinicians in this group
Hospitals listed: University of Wi Hospitals & Clinics Authority. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Kelsey A Hand’s office to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- University of Wi Hospitals & Clinics AuthorityMadison, WIAcute Care Hospital · Government - Hospital District or Authority · Has an emergency departmentPart of UW Health, which runs 3 hospitals in 2 statesHome of University of Wisconsin Carbone Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 82% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.93 (3.64 to 6.22) · 5,729 cases, Jul 2022 – Jun 2024Worse than the national rate — SSI - Colon Surgery: 1.52, Oct 2024 – Sep 2025Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.485, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.593, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.613, Oct 2024 – Sep 2025
See every measure and the patient survey for University of Wi Hospitals & Clinics Authority
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 2 better, 6 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.93 (3.64 to 6.22) · 5,729 cases | Worse | Jul 2022 – Jun 2024 |
| SSI - Colon SurgeryInfections | 1.52 | Worse | Oct 2024 – Sep 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.485 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.593 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.613 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.41 (0.74 to 2.09) · 4,035 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.04 (0.87 to 1.22) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 181.11 (148.97 to 213.24) · 341 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.1 · 173 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 126 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.6 · 365 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.5 · 619 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 9.3 · 582 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.7 · 523 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.5 · 6,380 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0.04 to 0.37) · 14,967 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.06 to 0.39) · 16,098 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.76 to 2.84) · 3,095 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.56 (1.56 to 3.56) · 4,743 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.25 (6.19 to 12.31) · 2,990 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.89 (2.03 to 5.75) · 3,097 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2 (0.84 to 3.16) · 1,690 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.71 (0.33 to 1.09) · 13,588 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 194 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.707 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.405 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 487 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 939 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -2 · 407 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -5.7 · 700 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.6 · 592 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 718 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.5 (5.4 to 7.9) · 1,266 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (8.2 to 11.4) · 1,266 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 203 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.8 · 170 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.6 · 234 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.2 (10.2 to 14.7) · 7,655 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1) · 2,865 cases | No different | Jan 2024 – Dec 2024 |
What patients said (3,209 patients answered, 34% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 5 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 91% |
| Yes, staff "did" give patients information about help after discharge | 91% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 80% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 57% |
| "YES", patients would definitely recommend the hospital | 82% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
Original Medicare doctor bills
$25,423
Medicare paid this office $25,423 for 130 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 83 | $4,729 | $45 |
| Return visit (30+ min) | 30 | $2,118 | $68 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 86 | $898 | $9 |
| Insertion of needle into vein for collection of blood sample | 33 | $433 | $9 |
Procedures Medicare counted
| Removal of skin lesions | 1-10 | None |
| Skin biopsy | 1-10 | None |
Who their Medicare patients are
130 Original Medicare patients in 2024. Average age 70 · Women 67% · Also on Medicaid 15% · Health risk score 1.09. At or below the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 49% · Diabetes 28% · Depression 23% · Heart failure 15% · Cancer 13% · Atrial fibrillation 13% · Coronary heart disease 12% · Chronic kidney disease 11% · COPD 11%.
The office billed $105,712, Medicare allowed $33,677 and paid $25,423; for 4,214 services of 37 kinds; $14,234 of it was for drugs given in the office and $11,189 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 130 | 4,214 | 70 | 1.09 | $105,712 | $25,423 |
| 2023 | 135 | 4,914 | 69 | 0.90 | $122,797 | $31,401 |
| 2022 | 160 | 3,476 | 71 | 1.00 | $113,191 | $27,471 |
| 2021 | 158 | 2,354 | 68 | 0.94 | $81,098 | $16,972 |
| 2020 | 130 | 505 | 68 | 1.19 | $48,403 | $8,571 |
| 2019 | 122 | 364 | 69 | 1.12 | $46,138 | $9,260 |
| 2018 | 149 | 408 | 71 | 1.06 | $53,817 | $8,389 |
| 2017 | 171 | 692 | 68 | 1.14 | $72,736 | $15,769 |
| 2016 | 175 | 626 | 69 | 1.23 | $74,908 | $16,405 |
| 2015 | 157 | 520 | 69 | 1.00 | $63,001 | $13,549 |
| 2014 | 175 | 823 | 68 | 1.01 | $78,449 | $15,762 |
| 2013 | 172 | 627 | 70 | 0.99 | $69,761 | $15,634 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Short return visit (20+ min) | 89 | $5,007 | $46 |
| Return visit (30+ min) | 20 | $1,514 | $63 |
| Insertion of needle into vein for collection of blood sample | 36 | $403 | $8 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 19 | $127 | $6 |
2022: 7 services
| Short return visit (20+ min) | 74 | $3,487 | $43 |
| Return visit (30+ min) | 39 | $3,064 | $77 |
| Short return visit | 15 | $433 | $27 |
| Administration of influenza virus vaccine | 13 | $363 | $28 |
| Insertion of needle into vein for collection of blood sample | 43 | $174 | $3 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 14 | $102 | $6 |
| Manual urinalysis test with examination using microscope, automated | 12 | $41 | $3 |
2021: 11 services
| Return visit (30+ min) | 45 | $3,005 | $64 |
| Short return visit (20+ min) | 56 | $2,076 | $33 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 16 | $1,063 | $66 |
| Blood test, thyroid stimulating hormone (tsh) | 15 | $319 | $17 |
| Administration of influenza virus vaccine | 18 | $292 | $16 |
| Hemoglobin a1c level | 23 | $243 | $10 |
| Insertion of needle into vein for collection of blood sample | 43 | $156 | $3 |
| Blood test, lipids (cholesterol and triglycerides) | 11 | $147 | $13 |
| Blood test, comprehensive group of blood chemicals | 12 | $127 | $11 |
| Blood test, basic group of blood chemicals (calcium, total) | 14 | $112 | $8 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 16 | $104 | $6 |
2020: 6 services
| Return visit (30+ min) | 50 | $2,467 | $46 |
| Short return visit (20+ min) | 42 | $1,568 | $37 |
| Blood test, thyroid stimulating hormone (tsh) | 14 | $234 | $17 |
| Administration of influenza virus vaccine | 11 | $179 | $16 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 17 | $110 | $6 |
| Insertion of needle into vein for collection of blood sample | 29 | $99 | $3 |
2019: 6 services
| Return visit (30+ min) | 58 | $3,774 | $57 |
| Short return visit (20+ min) | 47 | $1,966 | $39 |
| Blood test, thyroid stimulating hormone (tsh) | 11 | $220 | $18 |
| Blood test, lipids (cholesterol and triglycerides) | 11 | $160 | $15 |
| Insertion of needle into vein for collection of blood sample | 35 | $123 | $3 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 17 | $120 | $7 |
2018: 5 services
| Return visit (30+ min) | 61 | $3,284 | $49 |
| Short return visit (20+ min) | 66 | $1,842 | $25 |
| Blood test, thyroid stimulating hormone (tsh) | 13 | $285 | $20 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 16 | $203 | $8 |
| Insertion of needle into vein for collection of blood sample | 33 | $144 | $3 |
2017: 9 services
| Return visit (30+ min) | 86 | $5,827 | $57 |
| Short return visit (20+ min) | 65 | $2,919 | $38 |
| Blood test, thyroid stimulating hormone (tsh) | 25 | $587 | $23 |
| Administration of influenza virus vaccine | 12 | $291 | $24 |
| Administration of pneumococcal vaccine | 11 | $267 | $24 |
| Insertion of needle into vein for collection of blood sample | 46 | $179 | $3 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 14 | $157 | $10 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 12 | $120 | $10 |
| Automated urinalysis test | 13 | $42 | $3 |
2016: 8 services
| Return visit (30+ min) | 84 | $5,930 | $58 |
| Short return visit (20+ min) | 85 | $3,386 | $36 |
| Administration of influenza virus vaccine | 15 | $359 | $24 |
| Blood test, thyroid stimulating hormone (tsh) | 13 | $292 | $22 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 11 | $239 | $10 |
| Insertion of needle into vein for collection of blood sample | 43 | $188 | $3 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 12 | $104 | $9 |
| Automated urinalysis test | 16 | $54 | $3 |
2015: 9 services
| Return visit (30+ min) | 83 | $5,693 | $54 |
| Short return visit (20+ min) | 51 | $2,033 | $37 |
| Blood test, thyroid stimulating hormone (tsh) | 22 | $605 | $22 |
| Administration of influenza virus vaccine | 14 | $336 | $24 |
| Insertion of needle into vein for collection of blood sample | 51 | $197 | $3 |
| Blood test, basic group of blood chemicals (calcium, total) | 13 | $189 | $11 |
| Blood test, lipids (cholesterol and triglycerides) | 11 | $175 | $16 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 11 | $104 | $9 |
| Manual urinalysis test with examination using microscope, automated | 15 | $63 | $4 |
2014: 16 services
| Return visit (30+ min) | 91 | $6,236 | $56 |
| Short return visit (20+ min) | 55 | $2,532 | $38 |
| Blood test, thyroid stimulating hormone (tsh) | 12 | $404 | $22 |
| Annual depression screening, 5 to 15 minutes | 28 | $403 | $14 |
| Blood test, lipids (cholesterol and triglycerides) | 24 | $332 | $14 |
| Administration of influenza virus vaccine | 12 | $284 | $24 |
| Insertion of needle into vein for collection of blood sample | 61 | $249 | $3 |
| Blood test, comprehensive group of blood chemicals | 11 | $189 | $14 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 17 | $177 | $10 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 15 | $156 | $9 |
| Blood test, basic group of blood chemicals (calcium, total) | 13 | $128 | $10 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 11 | $97 | $9 |
| Liver enzyme (sgpt), level | 15 | $70 | $4 |
| Manual urinalysis test with examination using microscope, automated | 15 | $63 | $4 |
| Blood creatinine level | 14 | $61 | $4 |
| Blood potassium level | 14 | $49 | $3 |
2013: 13 services
| Return visit (30+ min) | 96 | $6,124 | $54 |
| Short return visit (20+ min) | 49 | $2,235 | $39 |
| Long return visit (40+ min) | 18 | $1,549 | $82 |
| Administration of influenza virus vaccine | 18 | $441 | $24 |
| Blood test, thyroid stimulating hormone (tsh) | 15 | $364 | $23 |
| Blood test, basic group of blood chemicals (calcium, total) | 30 | $355 | $10 |
| Influenza vaccine split virus, preservative free | 11 | $341 | $31 |
| Insertion of needle into vein for collection of blood sample | 57 | $222 | $3 |
| Bacterial colony count, urine | 17 | $208 | $11 |
| Blood test, lipids (cholesterol and triglycerides) | 11 | $157 | $14 |
| Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | 11 | $140 | $12 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 13 | $131 | $9 |
| Manual urinalysis test with examination using microscope, automated | 23 | $125 | $4 |
Medicaid work
$4,797 in 2024
Medicaid paid $4,797 for 123 billed services this clinician did in 2024, up to 22 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 123 | $4,797 |
| 2024 | 123 | 1 | 22 | $4,797 |
| 2023 | 194 | 1 | 24 | $3,925 |
| 2022 | 51 | 2 | 18 | $633 |
| 2021 | 26 | 1 | 13 | $258 |
| 2018 | 54 | 2 | 12 | $610 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 194 | $3,925 |
2022
| Short return visit (20+ min) | 36 | $340 |
| Return visit (30+ min) | 15 | $293 |
2021
| Short return visit (20+ min) | 26 | $258 |
2018
| Short return visit (20+ min) | 28 | $306 |
| Return visit (30+ min) | 26 | $305 |
Drugs they prescribed that Part D paid
$105,977
Pharmacies billed $105,977 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (27 of 865) in 2024. Above the middle of the specialty; the typical physician assistant clinician is at 1%.
695 generic and fewer than 11 brand-name prescriptions · $105,977 in drug cost · 61 antibiotic prescriptions to 42 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Trulicity | 15 | $14,317 | $954 |
| Combivent Respimat | 11 | $14,085 | $1,280 |
| Mounjaro | 14 | $13,887 | $992 |
| Eliquis | 13 | $9,744 | $750 |
| Adderall Xr | 20 | $2,130 | $107 |
See all 22 drugs
| Trulicity | 15 | $14,317 | $954 |
| Combivent Respimat | 11 | $14,085 | $1,280 |
| Mounjaro | 14 | $13,887 | $992 |
| Eliquis | 13 | $9,744 | $750 |
| Adderall Xr | 20 | $2,130 | $107 |
| Atorvastatin | 42 | $463 | $11 |
| Diphenhydramine | 19 | $342 | $18 |
| Losartan | 19 | $246 | $13 |
| Gabapentin | 23 | $245 | $11 |
| Metformin Hcl Er | 26 | $203 | $8 |
| Sucralfate | 11 | $190 | $17 |
| Amlodipine Besylate | 30 | $183 | $6 |
| Famotidine | 12 | $155 | $13 |
| Levothyroxine | 21 | $147 | $7 |
| Omeprazole | 12 | $141 | $12 |
| Hydroxyzine | 18 | $126 | $7 |
| Lisinopril | 19 | $120 | $6 |
| Amoxicillin-Clavulanate Potass | 14 | $117 | $8 |
| Tizanidine | 13 | $113 | $9 |
| Doxycycline Hyclate | 11 | $105 | $10 |
| Furosemide | 18 | $89 | $5 |
| Hydrochlorothiazide | 11 | $59 | $5 |
Year by year
| 2024 | 865 | 228 | 3% (27) | None | $105,977 |
| 2023 | 887 | 216 | 3% (29) | None | $100,861 |
| 2022 | 809 | 258 | 8% (61) | None | $62,721 |
| 2021 | 835 | 253 | 5% (45) | None | $79,133 |
| 2020 | 863 | 253 | 3% (29) | None | $89,811 |
| 2019 | 457 | 145 | 3% (13) | None | $25,220 |
| 2018 | 637 | 194 | 5% (31) | None | $47,073 |
| 2017 | 718 | 187 | 6% (40) | None | $48,154 |
| 2016 | 856 | 177 | 6% (50) | None | $40,684 |
| 2015 | 1,042 | 187 | 6% (63) | None | $65,550 |
| 2014 | 1,155 | 204 | 8% (93) | None | $65,100 |
| 2013 | 1,477 | 267 | 5% (78) | 18% | $67,812 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 22 drugs
| Trulicity | 22 | $20,516 | $933 |
| Xarelto | 14 | $11,440 | $817 |
| Incruse Ellipta | 12 | $4,429 | $369 |
| Atorvastatin | 58 | $832 | $14 |
| Gabapentin | 22 | $470 | $21 |
| Levothyroxine | 29 | $453 | $16 |
| Trazodone | 23 | $387 | $17 |
| Losartan | 16 | $368 | $23 |
| Lisinopril | 32 | $314 | $10 |
| Fluticasone Propionate | 18 | $293 | $16 |
| Amlodipine Besylate | 34 | $279 | $8 |
| Metoprolol | 11 | $269 | $24 |
| Metformin Hcl Er | 16 | $238 | $15 |
| Furosemide | 24 | $201 | $8 |
| Doxycycline Hyclate | 18 | $161 | $9 |
| Pregabalin | 11 | $129 | $12 |
| Ondansetron Odt | 12 | $122 | $10 |
| Omeprazole | 12 | $117 | $10 |
| Amoxicillin-Clavulanate Potass | 12 | $106 | $9 |
| Carvedilol | 15 | $91 | $6 |
| Sumatriptan | 11 | $62 | $6 |
| Hydrochlorothiazide | 11 | $25 | $2 |
2022: 21 drugs
| Buprenorphine-Naloxone | 27 | $6,093 | $226 |
| Albuterol Sulfate Hfa | 13 | $1,005 | $77 |
| Levothyroxine | 36 | $635 | $18 |
| Fluticasone Propionate | 18 | $439 | $24 |
| Gabapentin | 24 | $379 | $16 |
| Oxycodone | 11 | $318 | $29 |
| Prazosin | 13 | $313 | $24 |
| Hydrocodone-Acetaminophen | 18 | $307 | $17 |
| Diclofenac | 20 | $288 | $14 |
| Clopidogrel | 11 | $208 | $19 |
| Omeprazole | 13 | $201 | $15 |
| Lisinopril | 29 | $169 | $6 |
| Sertraline | 12 | $162 | $14 |
| Metformin | 14 | $149 | $11 |
| Sumatriptan | 11 | $124 | $11 |
| Furosemide | 22 | $116 | $5 |
| Atorvastatin | 15 | $112 | $7 |
| Amlodipine Besylate | 16 | $112 | $7 |
| Simvastatin | 14 | $74 | $5 |
| Metformin Hcl Er | 12 | $72 | $6 |
| Losartan | 11 | $68 | $6 |
2021: 19 drugs
| Buprenorphine-Naloxone | 51 | $8,642 | $169 |
| Advair Diskus | 15 | $6,743 | $450 |
| Albuterol Sulfate Hfa | 18 | $1,317 | $73 |
| Valacyclovir | 11 | $917 | $83 |
| Clonidine | 12 | $890 | $74 |
| Synthroid | 11 | $764 | $69 |
| Levothyroxine | 30 | $443 | $15 |
| Irbesartan | 11 | $242 | $22 |
| Oxycodone | 14 | $209 | $15 |
| Hydroxyzine | 14 | $206 | $15 |
| Atorvastatin | 18 | $193 | $11 |
| Diclofenac | 11 | $181 | $16 |
| Omeprazole | 15 | $178 | $12 |
| Amoxicillin-Clavulanate Potass | 11 | $139 | $13 |
| Lisinopril | 19 | $113 | $6 |
| Prednisone | 14 | $108 | $8 |
| Amitriptyline | 12 | $92 | $8 |
| Losartan | 12 | $91 | $8 |
| Furosemide | 14 | $91 | $7 |
2020: 19 drugs
| Buprenorphine-Naloxone | 24 | $9,660 | $403 |
| Carbamazepine Er | 16 | $2,517 | $157 |
| Albuterol Sulfate Hfa | 17 | $1,068 | $63 |
| Oxybutynin Chloride Er | 13 | $688 | $53 |
| Mirtazapine | 25 | $541 | $22 |
| Venlafaxine Hcl Er | 13 | $432 | $33 |
| Fluticasone Propionate | 31 | $401 | $13 |
| Gabapentin | 15 | $278 | $19 |
| Doxycycline Hyclate | 16 | $269 | $17 |
| Omeprazole | 15 | $176 | $12 |
| Furosemide | 23 | $175 | $8 |
| Allopurinol | 17 | $173 | $10 |
| Lisinopril | 17 | $159 | $9 |
| Atorvastatin | 13 | $156 | $12 |
| Amoxicillin-Clavulanate Potass | 12 | $123 | $10 |
| Amlodipine Besylate | 13 | $119 | $9 |
| Alendronate | 21 | $107 | $5 |
| Hydrochlorothiazide | 25 | $89 | $4 |
| Methocarbamol | 11 | $74 | $7 |
2019: 7 drugs
| Levothyroxine | 22 | $530 | $24 |
| Fluticasone Propionate | 13 | $359 | $28 |
| Omeprazole | 23 | $284 | $12 |
| Lisinopril | 12 | $162 | $13 |
| Amlodipine Besylate | 13 | $130 | $10 |
| Hydrochlorothiazide | 13 | $83 | $6 |
| Atorvastatin | 11 | $81 | $7 |
2018: 12 drugs
| Lyrica | 13 | $5,465 | $420 |
| Atorvastatin | 26 | $517 | $20 |
| Omeprazole | 38 | $411 | $11 |
| Levothyroxine | 20 | $338 | $17 |
| Ondansetron Odt | 11 | $293 | $27 |
| Lisinopril | 17 | $152 | $9 |
| Losartan | 14 | $149 | $11 |
| Metformin Hcl Er | 18 | $127 | $7 |
| Hydrochlorothiazide | 29 | $116 | $4 |
| Furosemide | 20 | $115 | $6 |
| Gabapentin | 14 | $100 | $7 |
| Terazosin | 15 | $85 | $6 |
2017: 16 drugs
| Advair Diskus | 13 | $6,986 | $537 |
| Lantus Solostar | 13 | $5,752 | $442 |
| Lyrica | 12 | $3,293 | $274 |
| Ventolin Hfa | 14 | $857 | $61 |
| Atorvastatin | 28 | $656 | $23 |
| Voltaren | 12 | $610 | $51 |
| Levothyroxine | 20 | $476 | $24 |
| Omeprazole | 30 | $362 | $12 |
| Hydrocodone-Acetaminophen | 15 | $284 | $19 |
| Lisinopril | 24 | $156 | $6 |
| Metformin Hcl Er | 14 | $150 | $11 |
| Buspirone | 12 | $121 | $10 |
| Losartan | 14 | $120 | $9 |
| Furosemide | 21 | $112 | $5 |
| Simvastatin | 11 | $107 | $10 |
| Amlodipine Besylate | 12 | $89 | $7 |
2016: 25 drugs
| Lyrica | 13 | $3,879 | $298 |
| Divalproex | 24 | $563 | $23 |
| Omeprazole | 29 | $344 | $12 |
| Levothyroxine | 15 | $321 | $21 |
| Amitriptyline | 17 | $298 | $18 |
| Gabapentin | 11 | $260 | $24 |
| Hydrocodone-Acetaminophen | 17 | $223 | $13 |
| Pravastatin | 11 | $222 | $20 |
| Fluticasone Propionate | 15 | $214 | $14 |
| Metformin Hcl Er | 15 | $204 | $14 |
| Atorvastatin | 18 | $199 | $11 |
| Fluoxetine | 16 | $180 | $11 |
| Lisinopril | 22 | $161 | $7 |
| Sertraline | 16 | $161 | $10 |
| Metformin | 17 | $140 | $8 |
| Risperidone | 14 | $134 | $10 |
| Simvastatin | 11 | $115 | $10 |
| Ranitidine | 16 | $105 | $7 |
| Citalopram Hbr | 15 | $87 | $6 |
| Alprazolam | 12 | $87 | $7 |
| Cephalexin | 13 | $82 | $6 |
| Atenolol | 12 | $73 | $6 |
| Furosemide | 13 | $55 | $4 |
| Hydrochlorothiazide | 16 | $49 | $3 |
| Clonazepam | 11 | $48 | $4 |
2015: 30 drugs
| Lyrica | 24 | $6,971 | $290 |
| Qvar | 11 | $2,051 | $186 |
| Doxycycline Hyclate | 11 | $1,979 | $180 |
| Prempro | 13 | $1,757 | $135 |
| Levothyroxine | 45 | $1,398 | $31 |
| Gabapentin | 21 | $889 | $42 |
| Duloxetine | 15 | $871 | $58 |
| Enalapril Maleate | 14 | $794 | $57 |
| Oxycodone | 18 | $483 | $27 |
| Atorvastatin | 19 | $363 | $19 |
| Potassium Chloride | 19 | $362 | $19 |
| Omeprazole | 30 | $350 | $12 |
| Pioglitazone | 13 | $252 | $19 |
| Amitriptyline | 12 | $244 | $20 |
| Methimazole | 13 | $222 | $17 |
| Hydrocodone-Acetaminophen | 19 | $221 | $12 |
| Alprazolam | 13 | $211 | $16 |
| Simvastatin | 36 | $205 | $6 |
| Ranitidine | 14 | $164 | $12 |
| Alendronate | 33 | $163 | $5 |
| Metformin | 22 | $143 | $6 |
| Atenolol | 19 | $141 | $7 |
| Losartan | 13 | $140 | $11 |
| Citalopram Hbr | 13 | $121 | $9 |
| Lorazepam | 18 | $114 | $6 |
| Amlodipine Besylate | 14 | $94 | $7 |
| Lisinopril | 14 | $93 | $7 |
| Furosemide | 18 | $92 | $5 |
| Metoprolol | 11 | $88 | $8 |
| Hydrochlorothiazide | 21 | $83 | $4 |
2014: 31 drugs
| Bromocriptine Mesylate | 11 | $4,722 | $429 |
| Advair Diskus | 13 | $4,252 | $327 |
| Morphine Sulfate Er | 25 | $1,349 | $54 |
| Levothyroxine | 48 | $1,232 | $26 |
| Proair Hfa | 16 | $1,083 | $68 |
| Pravastatin | 16 | $981 | $61 |
| Taztia Xt | 12 | $742 | $62 |
| Enalapril Maleate | 26 | $452 | $17 |
| Omeprazole | 24 | $413 | $17 |
| Oxybutynin Chloride | 13 | $394 | $30 |
| Simvastatin | 45 | $345 | $8 |
| Metformin | 21 | $337 | $16 |
| Gabapentin | 19 | $330 | $17 |
| Oxycodone | 21 | $318 | $15 |
| Ondansetron Odt | 11 | $280 | $25 |
| Methimazole | 14 | $257 | $18 |
| Metoprolol | 26 | $248 | $10 |
| Hydrocodone-Acetaminophen | 18 | $232 | $13 |
| Carbamazepine | 13 | $204 | $16 |
| Lisinopril | 25 | $195 | $8 |
| Amlodipine Besylate | 16 | $194 | $12 |
| Prednisone | 12 | $170 | $14 |
| Ranitidine | 17 | $166 | $10 |
| Alendronate | 23 | $164 | $7 |
| Furosemide | 27 | $147 | $5 |
| Hydrochlorothiazide | 35 | $144 | $4 |
| Tramadol | 15 | $128 | $9 |
| Trazodone | 15 | $119 | $8 |
| Citalopram Hbr | 14 | $98 | $7 |
| Lorazepam | 11 | $58 | $5 |
| Atenolol | 12 | $54 | $4 |
2013: 46 drugs
| Flovent Hfa | 15 | $3,951 | $263 |
| Crestor | 17 | $3,569 | $210 |
| Diovan | 16 | $2,459 | $154 |
| Zetia | 13 | $2,128 | $164 |
| Pioglitazone | 15 | $1,725 | $115 |
| Metoprolol | 19 | $1,433 | $75 |
| Proair Hfa | 22 | $1,207 | $55 |
| Gabapentin | 33 | $1,155 | $35 |
| Morphine Sulfate Er | 30 | $1,095 | $36 |
| Omeprazole | 49 | $939 | $19 |
| Levothyroxine | 65 | $748 | $12 |
| Gemfibrozil | 19 | $680 | $36 |
| Atorvastatin | 22 | $654 | $30 |
| Topiramate | 16 | $547 | $34 |
| Escitalopram | 14 | $514 | $37 |
| Ventolin Hfa | 11 | $473 | $43 |
| Benazepril | 32 | $452 | $14 |
| Simvastatin | 27 | $449 | $17 |
| Fluticasone Propionate | 16 | $424 | $27 |
| Metformin | 34 | $336 | $10 |
| Atenolol | 51 | $332 | $7 |
| Oxycodone | 17 | $317 | $19 |
| Lovastatin | 15 | $292 | $19 |
| Bisoprolol | 11 | $291 | $26 |
| Sertraline | 21 | $274 | $13 |
| Paroxetine | 21 | $271 | $13 |
| Insulin | 11 | $247 | $22 |
| Donepezil | 16 | $239 | $15 |
| Warfarin | 28 | $233 | $8 |
| Citalopram Hbr | 17 | $210 | $12 |
| Enalapril Maleate | 14 | $196 | $14 |
| Hydrochlorothiazide | 43 | $194 | $5 |
| Pravastatin | 22 | $193 | $9 |
| Fluoxetine | 25 | $180 | $7 |
| Baclofen | 11 | $169 | $15 |
| Lisinopril | 20 | $166 | $8 |
| Cyclobenzaprine | 11 | $155 | $14 |
| Glipizide | 20 | $152 | $8 |
| Trazodone | 16 | $143 | $9 |
| Amlodipine Besylate | 22 | $142 | $6 |
| Furosemide | 22 | $140 | $6 |
| Metoprolol | 16 | $117 | $7 |
| Hydrocodone-Acetaminophen | 11 | $99 | $9 |
| Cephalexin | 11 | $92 | $8 |
| Ciprofloxacin | 11 | $61 | $6 |
| Lorazepam | 11 | $47 | $4 |
Professional record
- NPI
- 1598063661
- Licence
- WI 2711
- Trained
- Yale University School of Medicine, 2010 · 16 years ago
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X)
- Mailing address
- 7974 Uw Health Ct, Middleton, WI, 53562
- NPI first listed
- 2011-03-14
- NPI last updated
- 2021-02-17
- NPI record certified
- 2021-02-17
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.